USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Details for Australian Patent Application No. 2002364163 (hide)

Owner HEMISPHERX BIOPHARMA

Inventors CARTER, William, A.; STRAYER, David, R.

Pub. Number AU-A-2002364163

PCT Number PCT/US02/39890

PCT Pub. Number WO2003/051301

Priority 60/339,390 14.12.01 US

Filing date 13 December 2002

Wipo publication date 30 June 2003

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/339,390 14.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002364163

16 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364164-CONVERSION SCHEME FOR USE BETWEEN DTX AND NON-DTX SPEECH CODING SYSTEMS

2002364162-SULFHYDRYL RIFAMYCINS AND USES THEREOF